Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-22-009733

Options or other derivatives

  • President & CEO acquired 275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GOOD JENNIFER L · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-14 Grant or award : show line 1 in the form Stock Option (right to buy) +275,000 275,000 D
Loading xslF345X03/doc4.xml…